7.5
Jednokompartmentowy model otwarty do podawania bolusa dożylnego: Oszacowanie klirensu
Klirens jest kluczowym parametrem farmakokinetycznym, który określa objętość płynu ustrojowego, z którego lek jest całkowicie usuwany w określonych ra…
Klirens oznacza teoretyczną objętość płynu, z której lek jest całkowicie usuwany w określonym przedziale czasowym, wyrażoną jako objętość w jednostce czasu. Zapewnia wgląd w dawkowanie leków i przewiduje potencjalne skutki uboczne.
Podany wzór oblicza klirens leku w jednokomorowym modelu otwartym.
Klirens narządowy szacuje się, dzieląc szybkość eliminacji narządu przez stężenie leku, które jest mu przedstawione.
Całkowity klirens ustrojowy lub ogólnoustrojowy obejmuje skumulowany klirens przez poszczególne narządy, takie jak nerki, wątroba itp.
Równanie modelu jednoprzedziałowego wyraża szybkość eliminacji, jak pokazano we wzorze.
Alternatywnie, w przypadku leków o nieznanej szybkości eliminacji, klirens można oszacować metodą bezkompartmentową.
View the full transcript and gain access to JoVE Core videos
Q1: What does clearance mean in pharmacokinetics?
Clearance is a key pharmacokinetic parameter that quantifies the theoretical volume of body fluid from which a drug is completely removed within a specific time frame. Expressed as volume per unit time, it provides critical insights into drug dosing and helps anticipate potential side effects by revealing how efficiently the body eliminates a drug.
Q2: How is clearance calculated in the one-compartment open model for IV bolus administration?
In the one-compartment open model for IV bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent volume of distribution to provide a quantitative measure of drug removal from the body.
Q3: What is the difference between organ clearance and total body clearance?
Organ clearance is estimated by dividing an individual organ's elimination rate by the drug concentration presented to that organ, such as hepatic or renal clearance. Total body clearance represents the cumulative clearance by all eliminating organs combined, illustrating how the entire body processes the drug.
Q4: How does hepatic clearance differ from other organ clearances?
Hepatic clearance evaluates drug elimination specifically by the liver and is estimated by dividing the elimination rate by the drug concentration presented to the liver. It can be further categorized into hepatic blood flow rate-limited clearance and intrinsic capacity-limited clearance, reflecting different mechanisms of liver-mediated drug removal.
Q5: What is the method of residuals used for in clearance estimation?
The method of residuals is a technique used to calculate clearance by separating multiexponential plasma concentration-time curves into their individual components. By analyzing these profiles and applying suitable equations, this method enables accurate estimation of clearance to understand drug elimination from the body.
Q6: When is the non-compartment method used for clearance estimation?
The non-compartment method is used to estimate clearance for drugs with unknown or complex elimination rate processes. This model-independent approach provides an alternative to compartmental analysis when the specific elimination mechanisms cannot be clearly defined or characterized from available data.
Q7: How do kidney and other organ clearances relate to total systemic clearance?
Drug clearance in the kidneys and other organs is estimated similarly by dividing the elimination rate by the drug concentration presented to each organ. Total systemic clearance is the aggregate of all individual organ clearances, demonstrating how multiple organs collectively contribute to overall drug elimination from the body.